{"product_id":"10th-annual-hematology-and-medical-oncology-board-review-contemporary-practice-2022","title":"10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice 2022","description":"\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv id=\"block-pagetitle\"\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003ch1 class=\"product-title product_title entry-title\"\u003e10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice 2022\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003eFormat : 41 Videos + 41 PDFs\u003c\/li\u003e\n\u003cli\u003eFile Size : 6.34 GB\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003eHematology and Medical Oncology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eDate \u0026amp; Location\u003c\/strong\u003e\u003c\/div\u003e\n\u003cp\u003eFriday, March 11, 2022, 9:00 AM – Monday, March 14, 2022, 1:00 PM EST\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eSpecialties\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cp\u003eThis four-day live course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Each lecture will conclude with a live Q\u0026amp;A with esteemed MSK course faculty.\u003c\/p\u003e\n\u003cp\u003eAdditionally, registered attendees will receive access to an online course syllabus, which includes select PDFs of the faculty presentations (slides) and recorded videos from the course.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWho Should Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe target audience for this well-received annual program includes medical oncology professionals – physicians, nurses, pharmacists, fellows and residents.\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eObjectives\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDefine state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers\u003c\/li\u003e\n\u003cli class=\"active\"\u003eDiscuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice\u003c\/li\u003e\n\u003cli\u003ePrepare for ABIM examinations in medical oncology and hematology\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers\u003c\/li\u003e\n\u003cli\u003e Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice\u003c\/li\u003e\n\u003cli\u003e Prepare for ABIM examinations in medical oncology and hematology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eProgram : \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSOLID TUMOR SESSION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eColon Cancer Leonard B. Saltz, MD\u003c\/p\u003e\n\u003cp\u003eMelanoma Paul B. Chapman, MD\u003c\/p\u003e\n\u003cp\u003eProstate Cancer Susan F. Slovin, MD, PhD\u003c\/p\u003e\n\u003cp\u003eKidney Cancer Robert J. Motzer, MD\u003c\/p\u003e\n\u003cp\u003eUrothelial Cancer Gopa Iyer, MD\u003c\/p\u003e\n\u003cp\u003eTestis Cancer Darren R. Feldman, MD\u003c\/p\u003e\n\u003cp\u003eUterine\/Cervix\/Other GYN Cancers Carol Aghajanian, MD\u003c\/p\u003e\n\u003cp\u003eOvarian Cancer Rachel N. Grisham, MD\u003c\/p\u003e\n\u003cp\u003eBreast Cancer: Surgery Hiram S. Cody III, MD, FACS\u003c\/p\u003e\n\u003cp\u003eBreast Cancer: Radiation Therapy Beryl McCormick, MD, FACR\u003c\/p\u003e\n\u003cp\u003eGenetics Zsofia K. Stadler, MD\u003c\/p\u003e\n\u003cp\u003eSmall Cell Lung Cancer W. Victoria Lai, MD\u003c\/p\u003e\n\u003cp\u003eBreast Cancer: Adjuvant Therapy Chau T. Dang, MD\u003c\/p\u003e\n\u003cp\u003eBreast Cancer: Advanced Disease Rachel Sanford, MD\u003c\/p\u003e\n\u003cp\u003eBreast Cancer: Hormonal Therapy Julia Brockway-Marchello, MD\u003c\/p\u003e\n\u003cp\u003eCarcinoma of Unknown Primary Anna M. Varghese, MD\u003c\/p\u003e\n\u003cp\u003eHepatocellular Cancer and Cholangiocarcinoma Ghassan K. Abou-Alfa, MD, MBA\u003c\/p\u003e\n\u003cp\u003ePancreatic and Neuroendocrine Cancer Eileen M. O’Reilly, MD\u003c\/p\u003e\n\u003cp\u003eNon Small Cell Lung Cancer Gregory J. Riely, MD, PhD\u003c\/p\u003e\n\u003cp\u003eHead and Neck, Thyroid,\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNon-melanoma Skin Cancer\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLara A. Dunn, MD\u003c\/p\u003e\n\u003cp\u003eAnal\/Rectal Cancer Andrea Cercek, MD\u003c\/p\u003e\n\u003cp\u003eEsophageal\/Gastric Cancer David H. Ilson, MD, PhD, FACP, FASCO\u003c\/p\u003e\n\u003cp\u003eCNS Tumors Christian Grommes, MD\u003c\/p\u003e\n\u003cp\u003eSarcoma Mark A. Dickson, MD\u003c\/p\u003e\n\u003cp\u003eInfectious Disease Susan K. Seo, MD\u003c\/p\u003e\n\u003cp\u003eMesothelioma Marjorie G. Zauderer, MD\u003c\/p\u003e\n\u003cp\u003ePharmacology Mrinal M. Gounder, MD\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMALIGNANT HEMATOLOGY SESSION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCAR T cells Michael Scordo, MD\u003c\/p\u003e\n\u003cp\u003eLow Grade NHL Andrew D. Zelenetz, MD, PhD\u003c\/p\u003e\n\u003cp\u003eCLL\/SLL Lindsey Roeker, MD\u003c\/p\u003e\n\u003cp\u003eDLBCL\/MCL\/BL Paul Hamlin, MD\u003c\/p\u003e\n\u003cp\u003eHL\/T Cell Alison J. Moskowitz, MD\u003c\/p\u003e\n\u003cp\u003eAuto\/Allo Gunjan Shah, MD\u003c\/p\u003e\n\u003cp\u003eALL Mark Blaine Geyer, MD\u003c\/p\u003e\n\u003cp\u003eAML Eytan Stein, MD\u003c\/p\u003e\n\u003cp\u003eMDS\/MPN Michael J. Mauro, MD\u003c\/p\u003e\n\u003cp\u003eMyeloma\/Amyloid Malin Hultcrantz\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBENIGN HEMATOLOGY SESSION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eApproach to The Bleeding Patient Rekha Paramewaran, MD\u003c\/p\u003e\n\u003cp\u003eThe Role of the New Direct Oral Anticoagulants in Practice\u003c\/p\u003e\n\u003cp\u003eSimon Mantha, MD, MPH\u003c\/p\u003e\n\u003cp\u003eThrombocytopenia, ITP and Beyond Cy Wilkins, MD\u003c\/p\u003e\n\u003cp\u003eSickle Cell Disease, Thalassemia Jodi Mones, MD\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecorded\/Review Date: March 11-14, 2022;\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOriginal Release Date: April 4, 2022;\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954640949346,"sku":"MED-AMB07354","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/10th-Annual-Hematology-and-Medical-Oncology-Board-Review-Contemporary-Practice-1024x256-1-768x192-1.jpg?v=1779381440","url":"https:\/\/meducourse.com\/products\/10th-annual-hematology-and-medical-oncology-board-review-contemporary-practice-2022","provider":"Meducourse","version":"1.0","type":"link"}